Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublocade in ED for Opioid Use Disorder
NCT04523792Phase 3Withdrawn
- Sponsor
- Virginia Commonwealth University
- Start
- Jan 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by Virginia Commonwealth University. Planned start Jan 2021; status: withdrawn.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04523792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04523792.